These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 31005381)

  • 1. The Abscopal Effect of Stereotactic Radiotherapy and Immunotherapy: Fool's Gold or El Dorado?
    Xing D; Siva S; Hanna GG
    Clin Oncol (R Coll Radiol); 2019 Jul; 31(7):432-443. PubMed ID: 31005381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abscopal regression following SABR for non-small-cell-lung cancer: A case report.
    Cong Y; Shen G; Wu S; Hao R
    Cancer Biol Ther; 2017 Jan; 18(1):1-3. PubMed ID: 27922336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review.
    Chicas-Sett R; Morales-Orue I; Castilla-Martinez J; Zafra-Martin J; Kannemann A; Blanco J; Lloret M; Lara PC
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052488
    [No Abstract]   [Full Text] [Related]  

  • 4. Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy?
    Walshaw RC; Honeychurch J; Illidge TM
    Br J Radiol; 2016 Oct; 89(1066):20160472. PubMed ID: 27556933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?
    Bernstein MB; Krishnan S; Hodge JW; Chang JY
    Nat Rev Clin Oncol; 2016 Aug; 13(8):516-24. PubMed ID: 26951040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The optimism surrounding stereotactic body radiation therapy and immunomodulation.
    Tharmalingam H; Hoskin PJ
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S9. PubMed ID: 28917247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abscopal Effect Following Immunotherapy and Combined Stereotactic Body Radiation Therapy in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma: A Report of Two Cases and Literature Review.
    Choi JS; Sansoni ER; Lovin BD; Lindquist NR; Phan J; Mayo LL; Ferrarotto R; Su SY
    Ann Otol Rhinol Laryngol; 2020 May; 129(5):517-522. PubMed ID: 31875405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future Directions.
    David S; Tan J; Siva S; Karroum L; Savas P; Loi S
    Biomedicines; 2022 Mar; 10(4):. PubMed ID: 35453571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer.
    Britschgi C; Riesterer O; Burger IA; Guckenberger M; Curioni-Fontecedro A
    Radiat Oncol; 2018 May; 13(1):102. PubMed ID: 29855323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using immunotherapy to boost the abscopal effect.
    Ngwa W; Irabor OC; Schoenfeld JD; Hesser J; Demaria S; Formenti SC
    Nat Rev Cancer; 2018 May; 18(5):313-322. PubMed ID: 29449659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging roles of stereotactic ablative radiotherapy for metastatic renal cell carcinoma.
    Cheung P; Thibault I; Bjarnason GA
    Curr Opin Support Palliat Care; 2014 Sep; 8(3):258-64. PubMed ID: 25090288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy.
    Blanchard M; Shim KG; Grams MP; Rajani K; Diaz RM; Furutani KM; Thompson J; Olivier KR; Park SS; Markovic SN; Pandha H; Melcher A; Harrington K; Zaidi S; Vile R
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):577-87. PubMed ID: 26461000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of the abscopal effect in preclinical models: Is the biologically effective dose a relevant physical trigger?
    Marconi R; Strolin S; Bossi G; Strigari L
    PLoS One; 2017; 12(2):e0171559. PubMed ID: 28222111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-1 Restrains Radiotherapy-Induced Abscopal Effect.
    Park SS; Dong H; Liu X; Harrington SM; Krco CJ; Grams MP; Mansfield AS; Furutani KM; Olivier KR; Kwon ED
    Cancer Immunol Res; 2015 Jun; 3(6):610-9. PubMed ID: 25701325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dynamic duo: A narrative review on the synergy between stereotactic body radiotherapy and immunotherapy in lung cancer treatment (Review).
    Cheng SH; Tu KY; Lee HH
    Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38874014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic ablative radiotherapy for colorectal cancer liver metastasis.
    Wang H; Li X; Peng R; Wang Y; Wang J
    Semin Cancer Biol; 2021 Jun; 71():21-32. PubMed ID: 32629077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the mechanisms involved in the abscopal effect and future directions with a focus on thymic carcinoma.
    Lesueur P; Chevalier F; Stefan D; Habrand JL; Lerouge D; Gervais R
    Tumori; 2017 May; 103(3):217-222. PubMed ID: 28291902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abscopal effect in pulmonary carcinoid tumor following ablative stereotactic body radiation therapy: a case report.
    Kareff SA; Lischalk JW; Krochmal R; Kim C
    J Med Case Rep; 2020 Oct; 14(1):177. PubMed ID: 33010806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic ablative body radiotherapy for lung cancer.
    Franks KN; Jain P; Snee MP
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):280-9. PubMed ID: 25746732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic Ablative Radio Therapy (SABR) followed by immunotherapy a challenge for individualized treatment of metastatic solid tumours.
    Masucci GV; Wersäll P; Kiessling R; Lundqvist A; Lewensohn R
    J Transl Med; 2012 May; 10():104. PubMed ID: 22616654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.